15/04/2015 - 22:00 Apremilast reduced the number and pain of oral ulcers in patients with Behçet’s syndrome in an industry-sponsored phase II trial, according to a re... More » Visit websiteField of Interest: DermatologyCategories: FPN || NewsFPN || DermatologyFPN || RheumatologyIMN || NewsIMN || DermatologyIMN || RheumatologySAN || Clinical NewsSAN || NewsNews Feed: Internal Medicine News - Dermatology